Outbreaks are linked to operational failures, lab settings, and personnel type, while not inactivating pathogens is strongly tied to mortality.
HHS should make more information public about how it mitigates risks for experiments that make pathogens more transmissible or virulent, a new report says.
Experts say the move will hobble the United States’ ability to respond to future infectious disease threats.
Japan’s guidance didn’t share any of the 10 key components with the US, while Canada had all 10, with wide variation in the remaining nations.
The suit from 19 states and the District of Columbia contends that major restructuring has cut life-saving programs and put extra burden on states to pay for health crises.
Following Listeria outbreaks and recalls, an ongoing review identified several steps that can be quickly implemented.
Though the funding covers melioidosis and Marburg tests, ASPR said the new capability can be repurposed to develop and produce tests for other biological threats when needed.
As a steady polio rise continues in Pakistan, the country has now reported 45 cases this year.
National stockpiles of smallpox vaccines, antivirals, and drugs are "imperfect" and limited, the authors say.
The recommendations include internationally accepted definitions of terminology, greater transparency with the public, and stronger biorisk-management systems and oversight.
